Allstate (ALL) Expected to Release Quarterly Earnings on Wednesday

Allstate (NYSE:ALL - Get Free Report) is expected to announce its Q1 2025 earnings results after the market closes on Wednesday, April 30th. Analysts expect Allstate to post earnings of $3.98 per share and revenue of $16.41 billion for the quarter.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. On average, analysts expect Allstate to post $19 EPS for the current fiscal year and $22 EPS for the next fiscal year.

Allstate Stock Down 0.9 %

Allstate stock traded down $1.84 during mid-day trading on Friday, hitting $193.02. The company had a trading volume of 1,156,082 shares, compared to its average volume of 1,614,301. Allstate has a 12 month low of $156.66 and a 12 month high of $212.91. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The stock's 50 day moving average price is $197.62 and its two-hundred day moving average price is $194.56. The company has a market capitalization of $51.16 billion, a PE ratio of 11.36, a price-to-earnings-growth ratio of 1.01 and a beta of 0.36.

Allstate Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were given a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 2.07%. This is an increase from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. Allstate's dividend payout ratio is 23.54%.

Allstate declared that its Board of Directors has initiated a stock repurchase program on Wednesday, February 26th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire up to 3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.

Insiders Place Their Bets

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This represents a 68.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Allstate stock. Brighton Jones LLC boosted its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 60.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,500 shares of the insurance provider's stock after buying an additional 2,443 shares during the quarter. Brighton Jones LLC's holdings in Allstate were worth $1,253,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 76.47% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ALL. Evercore ISI upgraded shares of Allstate from an "in-line" rating to an "outperform" rating in a report on Wednesday, January 8th. Wells Fargo & Company upped their price target on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a report on Tuesday, January 14th. Argus upgraded Allstate from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. JPMorgan Chase & Co. upped their target price on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Finally, Barclays reduced their price target on shares of Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $219.27.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.